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Siddiqui, Eisenberg et al. (2) reported a40-fold elevated peripheral 
blood level of FPA in all 31 patients diagnosed as having primary' 
pulmonary hypertension. Our findings do not distinguish increased 
thrombin activity in the left atrium of patients with mitral stenosis 
due to endothelial injury as a result of increased pulmonary vascular 
pressures from increased thrombin activity caused by the theologic 
abnormality in the left atrium. To show increased thrombin activity 
in the pulmonary circuit, it will be necessary to document he 
increases in plasma TAT and FPA levels in the pulmonary vein 
compared with those in the pulmonary artery. By contrast, activa- 
tion of the coagulation system in the left atrium of patients with 
mitral stenosis is supported by several recent reports on the relation 
of left atrial spontaneous echo contrast and atrial thrombus. In the 
study of Daniel et al. (3), patients with spontaneous left atrial echo 
contrast had a significantly larger left atrial diameter, a more 
frequent history of arterial embolization and a significantly higher 
incidence of left atrial thrombi than did patients without this 
phenomenon. In addition, we have observed that patients with 
hypertrophic ardiomyopathy exhibit hypercoagulability and that 
the activating site of coagulation is related to the enlarged left 
atrium in these patients (4). From these findings, we are tempted to 
conclude that the coagulation system is activated in the left atrium 
of patients with mitral stenosis as a result of rheologic abnormali- 
ties. 
The second issue might be a misunderstanding on the part of 
Siddiqui when he states that plasma TAT levels in our study were not 
significantly elevated in the left atrium of patients with mitral stenosis. 
Our findings showed that plasma TAT levels as well as FPA levels in 
the left atrium significantly exceeded those in the peripheral blood or 
the right atrium. Siddiqui also pointed out the possible influence of 
different blood sampling techniques on the hemostatic function tests. 
Our preliminary study showed no difference in the levels of biochem- 
ical markers in samples obtained from the same sites through the two 
types of catheters (a thermodilution catheter [7F] and an Inoue 
balloon catheter [12F]), and drawing from the same sites through these 
catheters did not cause an artificial increase in the levels of biochem- 
ical markers. The lack of difference in beta-thromboglobulin and 
platelet factor 4 levels among the peripheral vein and left and right 
atria provides further support that the blood sampling technique 
through two different catheters i not a fatal flaw in this study. Toy et 
al. (5) also reported that no significant difference was noted in any of 
the coagulation i dexes tudied between the blood that was and was 
not passed through arterial or pulmonary catheters. Therefore, we 
speculate that passage through the different catheters produced only 
trivial and statistically insignificant changes in the hemostatic function 
tests. 
Lip and Zarifis discuss the peripheral levels of biochemical markers 
of thrombogenesis and platelet activation i  chronic atrial fibrillation, 
mainly based on their recent publications. The objectives of our study 
were not to evaluate the peripheral levels of those markers in mitral 
stenosis, but, rather, to investigate the hemostatic status of the right 
and left atria in patients with mitral stenosis. 
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Methodology of Quantitating 
lntracoronary Ultrasound 
The article in the January issue of the Journal by Rickenbacher tal. 
(1) describing coronary artery disease in heart transplant recipients 
assessed by intracoronary ultrasound is an impressive collection of 
data. The importance of intracoronary ultrasound in the follow-up of 
patients with coronary artery disease, especially in heart transplant 
recipients, cannot be understated, and the authors have studied alarge 
number of patients at various intervals after transplantation. 
However, there are some problems with their methods of analysis. 
The most important point is that a mean of 3.0 _+ 0.1 sites/patient may 
not be accurate for individual patients for the following reasons: 1) For 
many heart ransplant recipients, the within-patient variance is so high 
that three sites per patient is insutficient for obtaining a precise value 
for the mean intimal thickness. We measured 20 random sites in the 
left anterior descending artery in heart ransplant recipients and found 
that measuring only three sites can lead to a standard error as high as 
80% of the mean. 2) The sampling method used is biased. The authors 
use the midpoint between branches as seen on angiography tochoose 
their intracoronary ultrasound site. It has been shown that coronary 
artery disease is frequently more severe near branch vessels (2,3); thus, 
sampling between branches can underestimate disease severity. We 
compared the mean measurements a  four sites between branches with 
four sites adjacent to branches in the left anterior descending artery in 
20 heart transplant recipients and found a significant difference 
between these measurements. 
By choosing only three sites per patient, Rickenbacher tal. did not 
statistically empower the study to show small differences between 
groups, which leads to attenuation f any statistical correlation toward 
zero. Therefore, conclusions cannot be drawn from any negative 
results. The same is true for comparing two groups. Using only three 
sites per patient would be valid only if the within-patient variance of 
intimal thickening were small compared with the between-patient 
variance, but we have found that not to be the case. In measuring 
transplant-recipient coronary artery disease with intracoronary ultra- 
sound we found that within-patient variance comprises -50% to 80% 
of the total variance. It has been shown by our investigation that 
approximately eight random sites in the left anterior descending 
coronary artery will minimize the variance and yield a more accurate 
representation f disease severity. 
Finally, in an age of computerized planimetry, the value of lumping 
several continuous and possibly independent variables into one of four 
Stanford classifications i questionable. A better understanding of the 
nature, distribution and progression of transplant-recipient coronary 
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artery disease will be achieved by examining the disease as precisely as 
possible and through serial, hmgitudinal studies. 
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Rep~ 
We appreciate the comments of Johnson and Kobashigawa regarding 
our article (1) in the Janua U issuc of the Journal. Clearly, there is no 
one "correct" method of performing and analyzing intravascular 
ultrasound imaging in transplant recipients. Each approach has its 
advantages and disadvantages. 
We agree with Johuson and Kobashigawa that the more sites 
analyzed per patient, the smaller the variance, given simple statistical 
rule. Also, the power to detect difference between groups will bc 
increased. However, in our study we did not state that there were no 
differences between groups when the p value was nonsignificant; 
rather, we stated that "all three [intravascular] variables further 
increased [given the increased mean I over time and reached highest 
values between years 5 and 15. 
The mean value for various groups, despite a larger variance, still 
represents mean value for the population. Clearly, in designing studies, 
the number of patients available and the variance will determine the 
power of the study. 
We do not think that our sampling method is more biased than 
"randomly chosen" 8 to 10 image sites. A randomly chosen 8 to 10 sites 
during a pullback may fall on positions that have suboptimal images. 
These positions may involve take-off of side branches, curvature of the 
artery,, resulting in dropout of one arterial wall, and artifacts obscuring 
the intimal thickening. Manual reselection of positions may be re- 
quired in any case. The issue of atherosclerosis often starting near side 
branches is an observation well substantiated in pathologic and 
physiologic studies (2). However, we are not aware of clinical data 
documenting more severe disease quantitatively near a side branch. 
Further studies in transplant-recipient or native coronary disease will 
he helpful. 
One of the purposes of our site approach is to allow us to follow 
lesion behavior over time so that we can better understand the 
pathophysiology of the disease process. A report on the reproducibility 
of this approach was presented at the 67th Scientific Sessions of the 
American Heart Association, in Dallas, Texas, November 1994 and 
published in Circulation (3,4). The Stanford Classification was created 
early on to qualitatively grade the intimal thickening and was never 
intended to be an independent variable. 
Clearly, the best approach for the study of coronary artery disease 
in transplant recipients is to three-dimensionally reconstruct he 
intimal thickening with automated border detection between lumen 
and intima, intima and media. We are currently finalizing the algo- 
rithm of such a program and intend to validate this method in our 
future studies. 
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